Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-22

Clinical Trial Update: The Effects of Dietary Supplement of Coenzyme Q10(CoQ10) on Dyslipidemia [Phase 3]

View source ↗

Summary

A completed Phase 3 trial evaluated the effects of a Coenzyme Q10 dietary supplement on dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Coenzyme Q10 (Coenzyme Q10)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Dyslipidemia | Phase 3 | Status: COMPLETED